SNHG7 and hepatocellular carcinoma: For example, in three distinct studies that reported survival analyses in HCC patients, among a total of 150 patients, poorer OS time was reported separately for the patients with elevated tissue SNHG7 expression in comparison to those with low levels (Yang et al., 2019; Zhao et al., 2021; Yao et al., 2019).